Health Care·Health Care Services·$21.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.61 | N/A | +0.63% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.61 | N/A | +0.63% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management remains focused on improving profitability and operational efficiency. They did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to enhance operational efficiency.
LabCorp's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 0.87%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue figures and future guidance could be contributing to investor caution.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
WELLS FARGO & CO
Oct 17, 2011